GAF Healthcare
Specialty Overview

Best Hospitals for Immunotherapy for Cancer in Bengaluru, India

11 cancer care hospitals in our India network are listed in Bengaluru, accredited by NABH, JCI, ISO, NABL, with 3,780 beds combined.

11
Hospitals Listed
1
City
4.5
Avg. Rating
5
Accreditation Types
The Short Answer

This page lists the cancer care hospitals in our directory offering Immunotherapy for Cancer in Bengaluru, India, including Narayana Health, Manipal Hospitals, HCG Cancer Centre, Medicover Hospital, Bangalore and others. Each listing links through to the hospital's full profile page.

Including:🇮🇳 Narayana Health🇮🇳 Manipal Hospitals🇮🇳 HCG Cancer Centre

Ask us about immunotherapy for cancer in Bengaluru, India

Share a few details and our care coordination team will get back to you with next steps.

Compare 11 accredited hospitals for Cancer Care in Bengaluru, India

Narayana Health Featured
Starting from$1,000

🇮🇳 Narayana Health

Bengaluru, India 4.8 (1750 reviews) 1,000 beds
Why consider this hospital?
4.8/5 rating from 1750 reviewsAccredited by NABH1,000 beds
Specialties & Accreditation
CardiacPediatric SurgeryCancer
Accredited by NABH

Patients considering immunotherapy for cancer can be cared for by Narayana Health's care team in Bengaluru, India, from initial consultation through recovery. Narayana Health, accredited by NABH, follows recognised patient-safety and quality-of-care standards when performing immunotherapy for cancer.

4.8/5
Rating
2000
Established
1,000
Beds
Bengaluru, India
Location
Enquire NowView Profile
Manipal Hospitals
Starting from$1,000

🇮🇳 Manipal Hospitals

Bengaluru, India 4.7 (1450 reviews) 600 beds
Why consider this hospital?
4.7/5 rating from 1450 reviewsAccredited by JCI, NABH600 beds
Specialties & Accreditation
OrthopedicsNeurologyIVF
Accredited by JCI, NABH

Patients considering immunotherapy for cancer can be cared for by Manipal Hospitals's care team in Bengaluru, India, from initial consultation through recovery. Manipal Hospitals, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing immunotherapy for cancer.

4.7/5
Rating
1991
Established
600
Beds
Bengaluru, India
Location
Enquire NowView Profile
HCG Cancer Centre
Starting from$1,000

🇮🇳 HCG Cancer Centre

Bangalore, India 4.7 (18 reviews) 150 beds
Why consider this hospital?
4.7/5 rating from 18 reviewsAccredited by NABH, JCI, ISO150 beds
Specialties & Accreditation
OncologyRadiation TherapyHaematologyCancer SurgeryBMT
Accredited by NABH, JCI, ISO

Patients considering immunotherapy for cancer can be cared for by HCG Cancer Centre's care team in Bangalore, India, from initial consultation through recovery. HCG Cancer Centre, accredited by NABH, JCI, ISO, follows recognised patient-safety and quality-of-care standards when performing immunotherapy for cancer.

4.7/5
Rating
1989
Established
150
Beds
Bangalore, India
Location
Enquire NowView Profile
Medicover Hospital, Bangalore
Starting from$1,000

🇮🇳 Medicover Hospital, Bangalore

Bengaluru, India 4.7 (68 reviews) 300 beds
Why consider this hospital?
4.7/5 rating from 68 reviewsAccredited by NABH300 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyOncologyNeurologyOrthopedicsUrology
Accredited by NABH

Patients considering immunotherapy for cancer can be cared for by Medicover Hospital, Bangalore's care team in Bengaluru, India, from initial consultation through recovery. Medicover Hospital, Bangalore, accredited by NABH, follows recognised patient-safety and quality-of-care standards when performing immunotherapy for cancer.

4.7/5
Rating
2024
Established
300
Beds
Bengaluru, India
Location
Enquire NowView Profile
Gleneagles Hospitals, Bengaluru
Starting from$1,000

🇮🇳 Gleneagles Hospitals, Bengaluru

Bengaluru, India 4.7 (142 reviews) 40 beds
Why consider this hospital?
4.7/5 rating from 142 reviewsAccredited by NABH40 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyOncologyNeurologyOrthopedicsGastroenterology
Accredited by NABH

Patients considering immunotherapy for cancer can be cared for by Gleneagles Hospitals, Bengaluru's care team in Bengaluru, India, from initial consultation through recovery. Gleneagles Hospitals, Bengaluru, accredited by NABH, follows recognised patient-safety and quality-of-care standards when performing immunotherapy for cancer.

4.7/5
Rating
2017
Established
40
Beds
Bengaluru, India
Location
Enquire NowView Profile
Manipal Hospital Malleshwaram (Northside)
Starting from$1,000

🇮🇳 Manipal Hospital Malleshwaram (Northside)

Malleshwaram, Bengaluru, India 4.6 (71 reviews) 83 beds
Why consider this hospital?
4.6/5 rating from 71 reviewsAccredited by NABH, NABL, ISO 900183 beds
Specialties & Accreditation
Cardiac SciencesOrthopedicsNeurosciencesGastroenterologyOncology
Accredited by NABH, NABL, ISO 9001

Patients considering immunotherapy for cancer can be cared for by Manipal Hospital Malleshwaram (Northside)'s care team in Malleshwaram, Bengaluru, India, from initial consultation through recovery. Manipal Hospital Malleshwaram (Northside), accredited by NABH, NABL, ISO 9001, follows recognised patient-safety and quality-of-care standards when performing immunotherapy for cancer.

4.6/5
Rating
1993
Established
83
Beds
Malleshwaram, Bengaluru, India
Location
Enquire NowView Profile
Manipal Hospital, Old Airport Road
Starting from$1,000

🇮🇳 Manipal Hospital, Old Airport Road

Bangalore, India 4.5 (87 reviews) 680 beds
Why consider this hospital?
4.5/5 rating from 87 reviewsAccredited by NABH, JCI680 beds
Specialties & Accreditation
Cardiac SurgeryNeurosciencesTransplantOncologyOrthopedics
Accredited by NABH, JCI

Patients considering immunotherapy for cancer can be cared for by Manipal Hospital, Old Airport Road's care team in Bangalore, India, from initial consultation through recovery. Manipal Hospital, Old Airport Road, accredited by NABH, JCI, follows recognised patient-safety and quality-of-care standards when performing immunotherapy for cancer.

4.5/5
Rating
1991
Established
680
Beds
Bangalore, India
Location
Enquire NowView Profile
Manipal Hospital Yeshwanthpur (Columbia Asia)
Starting from$1,000

🇮🇳 Manipal Hospital Yeshwanthpur (Columbia Asia)

Yeshwanthpur, Bangalore, India 4.5 (98 reviews) 168 beds
Why consider this hospital?
4.5/5 rating from 98 reviewsAccredited by NABH, JCI168 beds
Specialties & Accreditation
Cardiac SciencesOrthopedicsNeurosciencesOncologyGastroenterology
Accredited by NABH, JCI

Patients considering immunotherapy for cancer can be cared for by Manipal Hospital Yeshwanthpur (Columbia Asia)'s care team in Yeshwanthpur, Bangalore, India, from initial consultation through recovery. Manipal Hospital Yeshwanthpur (Columbia Asia), accredited by NABH, JCI, follows recognised patient-safety and quality-of-care standards when performing immunotherapy for cancer.

4.5/5
Rating
2008
Established
168
Beds
Yeshwanthpur, Bangalore, India
Location
Enquire NowView Profile
Manipal Hospital Millers Road (Vikram Hospital)
Starting from$1,000

🇮🇳 Manipal Hospital Millers Road (Vikram Hospital)

Millers Road, Bangalore, India 4.4 (74 reviews) 225 beds
Why consider this hospital?
4.4/5 rating from 74 reviewsAccredited by NABH225 beds
Specialties & Accreditation
Cardiac SciencesOrthopedicsNeurosciencesOncologyGastroenterology
Accredited by NABH

Patients considering immunotherapy for cancer can be cared for by Manipal Hospital Millers Road (Vikram Hospital)'s care team in Millers Road, Bangalore, India, from initial consultation through recovery. Manipal Hospital Millers Road (Vikram Hospital), accredited by NABH, follows recognised patient-safety and quality-of-care standards when performing immunotherapy for cancer.

4.4/5
Rating
2009
Established
225
Beds
Millers Road, Bangalore, India
Location
Enquire NowView Profile
Apollo Hospital, Bannerghatta Road
Starting from$1,000

🇮🇳 Apollo Hospital, Bannerghatta Road

Bangalore, India 4.2 (25 reviews) 250 beds
Why consider this hospital?
4.2/5 rating from 25 reviewsAccredited by JCI, NABH250 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyMedical OncologyBreast SurgerySpine SurgeryBariatric Surgery
Accredited by JCI, NABH

Patients considering immunotherapy for cancer can be cared for by Apollo Hospital, Bannerghatta Road's care team in Bangalore, India, from initial consultation through recovery. Apollo Hospital, Bannerghatta Road, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing immunotherapy for cancer.

4.2/5
Rating
2007
Established
250
Beds
Bangalore, India
Location
Enquire NowView Profile
Our Methodology

How we selected these hospitals

A hospital appears on this page when Cancer Care is among its listed specialties and it is located in Bengaluru, India. Hospitals are not ranked by a proprietary "best" score — the order follows the listed rating (highest first), the same field shown on each hospital's profile.

What To Look For

How to Select the Best Hospital for Immunotherapy for Cancer in Bengaluru, India?

Choosing the right hospital for immunotherapy for cancer is one of the most important decisions in your treatment journey. A few factors are worth weighing before you decide:

International Accreditation

Look for a hospital with international accreditation such as JCI or NABH — see the accreditation badges shown for each hospital below.

Specialization

Check that the hospital's listed specialties actually include cancer care rather than only general care.

Capacity and Track Record

Bed count and year established (shown below for each hospital) are a reasonable proxy for scale and operating experience.

Transparent Costs

Ask for an itemised, all-inclusive estimate — hospital charges, room category and stay — before you travel. Our cost calculator (linked below) gives a starting estimate.

Clinical Overview

Understanding Immunotherapy for Cancer

Cancer immunotherapy harnesses the body's own immune system to identify, attack, and eliminate malignant cells — representing one of the most significant paradigm shifts in oncology over the past two decades.

3–7 days per treatment cycle (outpatient infusions are common; inpatient admission required for CAR-T cell therapy and high-grade immune-related adverse events)
Hospital Stay
2–6 weeks minimum before international travel is medically cleared; CAR-T recipients typically require 4–8 weeks of local monitoring post-infusion
Total Stay in Country (Fit-to-Fly)
Objective response rates range from 15–45% for solid tumors with PD-1/PD-L1 checkpoint inhibitors; 70–85% complete remission rates reported for relapsed/refractory B-cell lymphoma with CAR-T (axicabtagene ciloleucel / tisagenlecleucel); outcomes are highly cancer-type and biomarker dependent
Success Rate

Clinical Overview

  • Cancer immunotherapy is a class of treatments that modulates or augments the immune system's capacity to recognize tumor-associated antigens (TAAs) and mount a sustained cytotoxic response against malignant cells.
  • Unlike conventional chemotherapy — which exerts cytotoxic effects on all rapidly dividing cells — immunotherapy is designed to achieve tumor-selective killing while generating immunological memory capable of preventing relapse.
  • The principal biological targets include immune checkpoint proteins (PD-1, PD-L1, CTLA-4, LAG-3, TIM-3), tumor-infiltrating lymphocyte (TIL) pathways, and surface antigens uniquely expressed on cancer cells such as CD19, CD20, HER2, and EGFR.
Full details →

Who is a Candidate?

  • ELIGIBILITY CRITERIA:
  • Patients with histologically or cytologically confirmed solid tumors or hematologic malignancies for whom immunotherapy has regulatory approval or strong Level 1 evidence (e.g., NSCLC, melanoma, bladder cancer, RCC, HCC, MSI-H colorectal cancer, triple-negative breast cancer, classical Hodgkin lymphoma, diffuse large B-cell lymphoma)
  • Patients with relapsed or refractory B-cell acute lymphoblastic leukemia (ALL) or large B-cell lymphoma who have failed ≥2 prior lines of systemic therapy (CAR-T eligibility)
  • ECOG Performance Status 0–2 (patients with PS 3–4 are generally not candidates for aggressive immunotherapy unless performance decline is directly disease-related and reversible)
  • +20 more

Treatment Options & Approaches

  • CHECKPOINT INHIBITOR THERAPY (ANTI-PD-1 / PD-L1 / CTLA-4):

Recovery

  • PHASE 1 — PRE-TREATMENT EVALUATION (WEEKS 1–3, OFTEN COMPLETABLE REMOTELY):

Risks to be aware of

  • Cancer immunotherapy carries a distinct and clinically significant toxicity profile that differs fundamentally from conventional chemotherapy.
  • The most consequential category is immune-related adverse events (irAEs), which result from non-specific immune activation affecting normal tissues.
Full details →

Why GAF Healthcare

  • GAF Healthcare provides a fully integrated, end-to-end medical travel coordination service that removes logistical barriers at every stage of the immunotherapy journey, allowing patients and their families to focus entirely on treatment and recovery.

Cost Range for Related Procedures

Cancer Surgery$4,000–$15,000
Chemotherapy$1,000–$4,000
Radiation Therapy$3,500–$10,000
Get a personalised estimate with our cost calculator →

Common questions about Immunotherapy for Cancer

What is the cost of Cancer Immunotherapy in India vs. the UAE?
The cost of cancer immunotherapy varies considerably depending on the specific agent or combination regimen, the number of treatment cycles required, and whether advanced modalities such as CAR-T cell therapy are part of the protocol. In India, a full course of checkpoint inhibitor therapy (e.g., pembrolizumab every 3 weeks for 6–12 months) typically costs between USD 8,000 and USD 45,000, while CAR-T cell therapy (including leukapheresis, manufacturing logistics, conditioning chemotherapy, infusion, and monitoring) ranges from approximately USD 40,000 to USD 75,000 at leading JCI- and NABH-accredited oncology centers in Mumbai, Delhi, Chennai, and Hyderabad. In the UAE (Dubai and Abu Dhabi), equivalent checkpoint inhibitor protocols range from USD 18,000 to USD 65,000, while CAR-T programs at JCI/DHA-accredited hospitals in Dubai Healthcare City and Abu Dhabi typically range from USD 80,000 to USD 140,000 — still representing a 60–70% cost reduction compared to the United States, where CAR-T product costs alone exceed USD 375,000–465,000 before hospital fees. The cost advantage in India is primarily driven by lower drug acquisition costs (domestic manufacturing of biosimilar checkpoint inhibitors is permitted), lower operational costs, and high treatment volume. The UAE commands a premium reflecting luxury hospital infrastructure, advanced nursing ratios, and geographic convenience for patients from the Middle East, GCC, and Africa. In both destinations, GAF Healthcare provides transparent, itemized cost estimates with no hidden fees before any commitment is made.
How long do I need to stay in the country before I am fit to fly home?
The minimum in-country stay required before you are medically cleared for international air travel depends significantly on the specific immunotherapy modality you receive. For checkpoint inhibitor therapy (pembrolizumab, nivolumab, ipilimumab, or combination regimens): The initial workup, biomarker testing, and Cycle 1 administration typically require 2–3 weeks in-country. Once Cycle 1 is complete and no Grade 2 or higher immune-related adverse events (irAEs) are present, most patients receive fit-to-fly clearance after 3–4 weeks total. Subsequent cycles (typically every 3–6 weeks) can often be administered at a GAF Healthcare partner facility closer to your home country. For CAR-T cell therapy: This requires a longer and non-negotiable in-country commitment. After leukapheresis (Day 1), there is typically a 2–4 week wait for cell manufacturing. Lymphodepleting chemotherapy begins 2–3 days before CAR-T infusion. Post-infusion, a minimum of 4 weeks of mandatory inpatient and outpatient monitoring is required to manage cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS), which can onset up to Day 14. A 28–30 day response assessment PET-CT is performed before discharge planning begins. The minimum realistic total in-country duration for CAR-T patients is 8–10 weeks. For all patients, a formal fit-to-fly letter is issued by the treating oncologist, and GAF Healthcare provides a structured medical summary for cabin crew and customs if required. Long-haul flights carry additional DVT risk in immunocompromised patients, and low-molecular-weight heparin prophylaxis may be recommended depending on thrombotic risk assessment.
What is the success rate of Cancer Immunotherapy?
The success rate of cancer immunotherapy is highly context-dependent and must be interpreted based on cancer type, molecular biomarker profile, treatment line, and the specific modality used. There is no single universal success rate; the figures below reflect the strongest published clinical data. For PD-1/PD-L1 checkpoint inhibitors in solid tumors: Objective response rates (ORR) range from 15–45% depending on PD-L1 expression and TMB status. In NSCLC with PD-L1 TPS ≥50%, pembrolizumab monotherapy achieves an ORR of approximately 45% and a 5-year overall survival rate of ~31% (Keynote-024 long-term follow-up). In metastatic melanoma treated with dual checkpoint blockade (nivolumab + ipilimumab), 5-year overall survival is approximately 52% (CheckMate 067). Patients with MSI-H/dMMR tumors across any cancer type treated with pembrolizumab or dostarlimab demonstrate ORRs of 40–57%, with a significant subset achieving durable complete responses. For CAR-T cell therapy: In relapsed/refractory large B-cell lymphoma, axicabtagene ciloleucel achieves complete remission rates of 58–73% in the third-line setting, with approximately 40% of patients maintaining response at 24 months. In relapsed/refractory B-cell ALL in pediatric/young adult patients, tisagenlecleucel achieves complete remission in approximately 81% of cases. For multiple myeloma treated with BCMA-targeting CAR-T (ciltacabtagene autoleucel), ORRs exceed 98% with stringent complete response rates of ~73% in heavily pretreated populations. It is essential to understand that 'success' in oncology is measured across multiple endpoints: overall survival, progression-free survival, complete remission, quality of life, and durable disease control. GAF Healthcare's partner oncologists provide individualized probability estimates based on your specific tumor profile, biomarker results, and treatment history during the initial teleconsultation — before any financial or travel commitment is made.

Related pages

How GAF Healthcare Assists in Choosing the Best Hospital for Immunotherapy for Cancer in Bengaluru, India

Discover the Top Hospitals for Immunotherapy for Cancer in Bengaluru, India

This page lists 11 accredited cancer care hospitals in Bengaluru, India, so you can compare accreditation, specialties and bed capacity in one place.

Support When You Need It Most

Share your medical reports with us on WhatsApp or email. Our medical team reviews them and comes back with a recommended hospital and treatment plan for your case.

Transparent, All-Inclusive Costs

We provide a single, itemised quote covering hospital charges and stay — no hidden fees, and there's no charge for requesting an estimate. Use our cost calculator alongside this page for a first estimate.

Visa, Travel and Stay Coordination

Once you choose a hospital, we help arrange the medical visa invitation letter, hotel or serviced-apartment booking nearby, airport pickup and transport to your appointments.

Curious what treatment might cost for your case? Use our cost calculator for a personalized estimate.

Common Questions

Frequently asked questions about immunotherapy for cancer in Bengaluru, India

How many cancer care hospitals are listed in Bengaluru, India?
11 hospitals in our Bengaluru, India directory are currently listed for cancer care including Immunotherapy for Cancer.
How do you choose which hospitals to list?
A hospital appears on this page when Cancer Care is among its listed specialties and it is located in Bengaluru, India. Hospitals are not ranked by a proprietary "best" score — the order follows the listed rating (highest first), the same field shown on each hospital's profile.
How much does treatment cost in India?
Cost varies by hospital, city and individual case. Use our cost calculator for a personalized estimate — see the link on this page.
Are there cancer care hospitals for this in other India cities?
See the "Hospitals in other cities" links on this page for the full India list.
Are these hospitals internationally accredited?
Hospitals listed on this page carry accreditations including NABH, JCI, ISO, NABL — see the accreditation badge shown for each hospital below.
Can I get a treatment plan and cost estimate before I travel?
Yes. Share your medical reports with the GAF Healthcare team over WhatsApp or email, and our medical team will review them and come back with a recommended hospital, a treatment plan and an itemised cost estimate before you commit to anything.
Do you help with visa, travel and accommodation?
Yes. Once you choose a hospital, our team helps arrange the medical visa invitation letter, book accommodation near the hospital, and organise airport pickup and transport to appointments.
What support do I get during and after treatment?
Our medical team reviews your reports and stays in touch throughout your treatment journey — from the first consultation through recovery, including after you return home.
What does the "Featured" label next to a hospital's name mean?
"Featured" reflects editorial prominence on this listing, not a clinical ranking or a claim that it is the "best" hospital.
How do I get matched with the right hospital for immunotherapy for cancer?
Share your medical reports and requirements with the GAF Healthcare team, and our medical coordinators will recommend a suitable hospital from this list based on your case.
Does the listed cost cover everything?
The figures shown are an indicative planning estimate, not a final quote from a specific hospital. Our team provides a single, itemised, all-inclusive quote before you make any commitment.
🤔

Still have questions?

Our coordinators are here to answer your questions about immunotherapy for cancer in Bengaluru, India.

Next Step

Share your medical reports with us and our team will recommend a hospital and treatment plan for immunotherapy for cancer in Bengaluru, India.

Contact us to report an inaccuracy on this page.

WhatsApp Us